✦ LIBER ✦

A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study)

✍ Scribed by Stebbing, J; Harrison, M; Glynne-Jones, R; Bridgewater, J; Propper, D

Book ID: 109999414
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 100 KB
Volume: 98
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6604232

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential intrahepatic and systemic flu

Sequential intrahepatic and systemic fluoropyrimidine-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II study

✍ Camillo Porta; Marco Danova; Salvatore Accurso; Carmine Tinelli; Margherita Giri 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 137 KB

A phase II study of epidoxorubicin in co

A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance

✍ Verweij, J; Herweijer, H; Oosterom, R; van der Burg, MEL; Planting, ASTh; Seynae 📂 Article 📅 1991 🏛 Nature Publishing Group 🌐 English ⚖ 744 KB

The effects of gefitinib in tamoxifen-re

The effects of gefitinib in tamoxifen-resistant and hormone-insensitive breast cancer: A phase II study

✍ Eleanor Gutteridge; Amit Agrawal; Robert Nicholson; Kwok Leung Cheung; John Robe 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 366 KB

## Abstract Estrogen receptor (ER)‐positive acquired tamoxifen‐resistant (TAM‐R) MCF‐7 breast cancer cell lines exhibit epidermal growth factor receptor (EGFR) expression/signaling and are growth‐inhibited by gefitinib (IRESSA). We examined the effect of gefitinib on ER‐positive TAM‐R and ER‐negati

Phase II trial of fortnightly irinotecan

Phase II trial of fortnightly irinotecan (CPT-11) in the treatment of colorectal cancer patients resistant to previous fluoropyrimidine-based chemotherapy

✍ Carlos García-Girón; Andrés García Palomo; Carmen Alonso López; Ángel León Carbo 📂 Article 📅 2005 🏛 Springer Milan 🌐 Spanish ⚖ 133 KB

133 A phase II study of oxaliplatin, cap

133 A phase II study of oxaliplatin, capecitabine and bevacizumab in the treatment of metastatic colorectal cancer

✍ N. Fernando; M. Morse; G. Blobe; L. Sutton; L. Odogwu; W. Honeycutt; M. Bauer; M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 144 KB

A Cancer Research (UK) randomized phase

A Cancer Research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen

✍ S.R.D. Johnston; L.A. Gumbrell; T.R.J. Evans; R.E. Coleman; I.E. Smith; C.J. Twe 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 238 KB